IP Library › Assignment 039735/0016
Patent Assignment
Reel/Frame 039735/0016

Change of Name

Recorded: 2016-08-18 Pages: 3
Assignor
BIOCEROS HOLDING B.V.
Executed: 2016-07-29
Assignee
CLUSTER40 THERAPEUTICS B.V.
YALELAAN 46, UTRECHT, 3584 CM, NETHERLANDS
Covered Properties (3)
Induction of Cytotoxic T Lymphocyte Responses Using Anti-CD40 Antibodies
Patent: 7,172,759 →
Application: 09/773,866 →
Publication: US 2001/0026932
CD40-Binding Activating Antibodies
Patent: 7,547,438 →
Application: 11/613,409 →
Publication: US 2007/0098720
Gene Constructs Coding for CD40-Binding Activating Antibodies
Patent: 7,820,807 →
Application: 12/420,481 →
Publication: US 2009/0311268
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 31, 2001
From: THOMAS, DAVID; BOER, MARK DE; RES, PIETER C.J.M.; SIMONS, PETER J.
To: TANOX, INC.
Reel/Frame 011854/0518 →
Assignment of Assignor's Interest Jul 25, 2006
From: TANOX, INC.
To: PANGENETICS BV
Reel/Frame 018001/0438 →
Assignment of Assignor's Interest Mar 6, 2015
From: PANGENETICS B.V.
To: BIOCEROS HOLDING B.V.
Reel/Frame 035106/0428 →
Assignment of Assignor's Interest Jul 27, 2017
From: CLUSTER40 THERAPEUTICS B.V.
To: MYCENAX BIOTECH INC.
Reel/Frame 043119/0407 →